NYSE:APR Apria (APR) Stock Price, News & Analysis → No experience to confident trader, meet my student… (From Wealth Builders Institute) (Ad) Free APR Stock Alerts Notice: This company has been marked as potentially delisted and may not be actively trading. Add Compare Share Share Today's Range$37.50▼$37.5050-Day Range$37.26▼$37.5052-Week Range$22.36▼$40.00VolumeN/AAverage Volume682,285 shsMarket Capitalization$1.34 billionP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock Analysis Get Apria alerts: Email Address Ad Colonial MetalsConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareThe latest flare-up between Israel and Palestinian militants has sent gold prices surging. Why? Because savvy investors know the endgame of the elites at play… Geopolitical crises breed uncertainty — and gold thrives on uncertainty. See why the elites are pouring billions into gold. About Apria Stock (NYSE:APR)Apria, Inc. provides integrated home healthcare equipment and related services in the United States. The company offers home respiratory therapies, including the supply of stationary and portable home oxygen equipment, and non-invasive ventilators; obstructive sleep apnea therapy devices comprising continuous positive airway pressure and bi-level positive airway pressure devices, and patient support services; and negative pressure wound therapy products. It also provides a range of home medical equipment and other products, and services for patients with home care needs; and clinical and administrative support services, and related products and supplies to patients. Apria, Inc. was incorporated in 2018 and is headquartered in Indianapolis, Indiana. As of March 29, 2022, Apria, Inc. operates as a subsidiary of Byram Healthcare Centers, Inc.Read More Ad Colonial MetalsConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareThe latest flare-up between Israel and Palestinian militants has sent gold prices surging. Why? Because savvy investors know the endgame of the elites at play… Geopolitical crises breed uncertainty — and gold thrives on uncertainty. See why the elites are pouring billions into gold. APR Stock News HeadlinesMay 4, 2024 | uk.finance.yahoo.comQ1 2024 Owens & Minor Inc Earnings CallApril 26, 2024 | msn.comCapria closes Rs 153 crore India Opportunity Fund following multi-fold returnfrom Awign exitMay 6, 2024 | InvestorPlace (Ad)$21,000 in profits in six weeks? On Wednesday, May 8, the legendary Jonathan Rose is holding his first ever Masters in Trading Summit. Jonathan is one of the sharpest traders I’ve ever met. He made millions trading in the pits of the world’s largest exchanges.April 22, 2024 | finance.yahoo.comAccessHope Secures $33 Million in Series B Funding to Expand Access to Leading Cancer ExpertiseApril 8, 2024 | msn.comWatch live total solar eclipse 2024 updates from NasaFebruary 22, 2024 | finance.yahoo.comDJO Whistleblower Law Group Plays Crucial Role in Lincare Fraud SettlementFebruary 21, 2024 | markets.businessinsider.comCritical Insights From Owens & Minor Analyst Ratings: What You Need To KnowFebruary 7, 2024 | newsweek.comAmerica's Greatest Workplaces for Women 2024 - Newsweek RankingsMay 6, 2024 | InvestorPlace (Ad)$21,000 in profits in six weeks? On Wednesday, May 8, the legendary Jonathan Rose is holding his first ever Masters in Trading Summit. Jonathan is one of the sharpest traders I’ve ever met. He made millions trading in the pits of the world’s largest exchanges.February 7, 2024 | newsweek.comAmerica's Greatest Workplaces for Women 2024 - Large Size CompaniesDecember 5, 2023 | finance.yahoo.comFortra Launches Cloud Email Protection to Combat the Rise of Advanced ThreatsNovember 13, 2023 | bizjournals.comRI-owned ExactCare adding tech, pharmacy benefits managementNovember 10, 2023 | bizjournals.comExactCare adding tech, pharmacy benefits management with business combinationOctober 3, 2023 | finance.yahoo.comPinnacle Treatment Centers Taps Michael Lawler as New CEOJuly 6, 2023 | msn.comLa voce delle Alpi, in Valsassina una giornata per tornare alle radici del territorioJune 14, 2023 | finance.yahoo.comMedical Equipment Rental Global Market Report 2023May 25, 2023 | benzinga.comSIRI & GLIMSTAD LLP & JOIN CLASS ACTIONS ANNOUNCE INVESTIGATION OF APRIA HEALTHCARE DATA BREACH - YOU MAY BE ENTITLED TO COMPENSATION!May 25, 2023 | finance.yahoo.comTomorrow Health Cements its Focus as the Premier Partner for Home-based Care Providers by Closing its Medical Supply BusinessMay 24, 2023 | msn.comPhilly Inquirer says Cuba ransomware gang's data leak claims are fake newsMay 23, 2023 | msn.comApria Healthcare says potentially 2M people caught up in IT security breachMay 22, 2023 | benzinga.comApria Notice of Data BreachMay 10, 2023 | marketwatch.comMedical Equipment Rental Market Size with Future Trends and Share with Revenue ForecastMay 9, 2023 | marketwatch.comAmbulatory Care Services Market 2023 Trends, Growth, Analysis, Opportunity and Forecast 2030May 9, 2023 | marketwatch.comFacial Interface Devices Market Outlook 2023 and Forecast to 2030 | DeVilbiss Healthcare LLC, Fisher & Paykel Healthcare, Philips HealthcareMay 6, 2023 | finance.yahoo.comQ1 2023 Owens & Minor Inc Earnings CallMay 4, 2023 | finance.yahoo.comHere’s Why Owens & Minor (OMI) is DecliningMay 3, 2023 | marketwatch.comHealthcare Equipment Leasing Market: Competitive Dynamics & Global Outlook 2030See More Headlines Receive APR Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Apria and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings11/04/2021Today5/06/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNYSE SectorMedical Industry Home Health Care Services Sub-IndustryN/A Current SymbolNYSE:APR CUSIPN/A CIK1735803 Webwww.apria.com Phone800-990-9799FaxN/AEmployees6,080Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$64.88 million Net Margins5.66% Pretax Margin7.84% Return on Equity586.18% Return on Assets9.23% Debt Debt-to-Equity Ratio8.58 Current Ratio1.09 Quick Ratio1.06 Sales & Book Value Annual Sales$1.15 billion Price / Sales1.17 Cash Flow$5.27 per share Price / Cash Flow7.12 Book Value$1.12 per share Price / Book33.48Miscellaneous Outstanding Shares35,645,000Free FloatN/AMarket Cap$1.34 billion OptionableNot Optionable BetaN/A Ten Starter Stocks For Beginners to Buy NowJust getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.Get This Free Report Key ExecutivesMr. Daniel J. Starck (Age 55)CEO & Director Comp: $1.8MMs. Debra L. Morris CPA (Age 63)CFO & Exec. VP Comp: $1.02MMr. Mark E. Litkovitz (Age 58)Chief Information Officer & Exec. VP Comp: $739.75kMr. Robert P. Walker (Age 55)Exec. VP of Managed Care Comp: $729.43kMr. Christopher G. Lee (Age 41)Chief Accounting Officer Mr. Michael-Bryant Hicks Esq. (Age 47)Exec. VP, Gen. Counsel & Corp. Sec. Ms. Celina M. Scally (Age 52)Sr. VP & Chief HR Officer Ms. Kimberlie K. Rogers-BowersSr. VP of Regulatory Affairs & Sr. VP of Acquisition IntegrationMr. James D. GlynnSr. VP of Infusion ServicesMs. Nichola DenneyExec. VP of Revenue ManagementMore ExecutivesKey CompetitorsAdaptHealthNASDAQ:AHCOAddus HomeCareNASDAQ:ADUSBrightSpring Health ServicesNASDAQ:BTSGEnhabitNYSE:EHABAveanna HealthcareNASDAQ:AVAHView All Competitors APR Stock Analysis - Frequently Asked Questions How were Apria's earnings last quarter? Apria, Inc. (NYSE:APR) announced its quarterly earnings results on Thursday, November, 4th. The company reported $0.52 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.48 by $0.04. The firm earned $287.20 million during the quarter, compared to analyst estimates of $286 million. Apria had a trailing twelve-month return on equity of 586.18% and a net margin of 5.66%. When did Apria IPO? Apria (APR) raised $150 million in an initial public offering (IPO) on Thursday, February 11th 2021. The company issued 7,500,000 shares at $19.00-$21.00 per share. Citigroup and Goldman Sachs & Co. LLC BofA Securities J.P. Morgan UBS Investment Bank served as the underwriters for the IPO and Piper Sandler Citizens Capital Markets Fifth Third Securities TD Securities Academy Securities Blaylock Van, LLC Penserra Securities LLC Stern was co-manager. This page (NYSE:APR) was last updated on 5/6/2024 by MarketBeat.com Staff From Our PartnersNo experience to confident trader, meet my student…Wealth Builders InstituteBiden’s $374B Giveaway Into This SectorDTIAI “wealth window” is closing June 25thParadigm Press2024 Oil BoomThe Oxford ClubMake this ONE trade on Tuesday at 2 p.m. EST!Monument Traders AllianceControversial CEO explains new way to amass wealthStansberry ResearchThe 2024 crypto bull run has already started — don’t get left behindInvestorPlaceTech GIANT’s Plans to Revolutionize Crypto…Crypto 101 Media Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Apria, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
